Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Deep learning based cancer grading for early detection from histology image biostatistics Ahmet Coskun Georgia Institute of Technology PLCO Nov 17, 2020 PLCOI-695
Using clinicopathological data to determine risk of metachronous advanced colorectal neoplasia among patients with adenomas Laura Hester Janssen Research and Development, LLC PLCO Nov 17, 2020 PLCO-688
An examination of the relationship between specific driver mutations, target drugs, and immunotherapies in non-small cell lung cancer survival outcomes. Lauren Connell Independent PLCO Nov 17, 2020 PLCO-691
Heterogeneous Odds Ratio Estimation Jean Pauphilet London Business School PLCO Nov 4, 2020 PLCO-686
Evaluating key determinants for the risk of second primary lung cancer among breast and colorectal cancer survivors using population-based screening trial data from the PLCO Summer Han Stanford University PLCO Oct 27, 2020 PLCO-683
Statistical Methods and Artificial Intelligence Deep Learning to Identify the Risk Factors of Colorectal Cancer Ranju Karki University of South Florida PLCO Oct 27, 2020 PLCO-684
Statistical Modelling on Pancreatic Cancer ADITYA CHAKRABORTY University of south Florida PLCO Oct 22, 2020 PLCO-680
Investigating multi-modal signatures of clinical outcome to immunotherapy in renal cell carcinoma Sachet Shukla Dana-Farber Cancer Institute PLCO Oct 22, 2020 PLCO-679
Statistical methods to identify the “causal SNP” from among SNPs in high LD with an index SNP Mitchell Gail National Cancer Institute PLCO Oct 22, 2020 PLCO-678
Predicting time to castration resistance in hormone sensitive prostate cancer Ari Robinson The Institute for Medical BioMathematics (IMBM) PLCO Oct 22, 2020 PLCO-677
Assessing the Risk and Cost of the Digital Rectal Exam: Is It Time to Abandon the DRE? Sanoj Punnen University of Miami Miller School of Medicine PLCO Oct 8, 2020 PLCO-671
Biological bases of lung cancer risk disparities for African American male smokers Chengguo Xing University of Florida PLCO Oct 8, 2020 PLCO-673
Clonal mosaic chromosomal alterations and mortality in PLCO Mitchell Machiela National Cancer Institute PLCO Oct 8, 2020 PLCO-674
The impact of diabetes on lung cancer incidence and prognosis according to histologic subtype Amanda Leiter Icahn School of Medicine at Mount Sinai PLCO Sep 22, 2020 PLCO-668
Serum levels of per- and polyfluorinated substances and risks of non-Hodgkin lymphoma and thyroid cancer Mark Purdue DCEG, NCI PLCO Sep 18, 2020 2020-0003
Cancer survival analysis using semisupervised learning method based on Cox and AFT models with L1/2 regularization Vaishali Gadhiya Laurentian University PLCO Sep 16, 2020 PLCO-666
Characteristics associated with weightlifting, cancer risk and associated mortality Jessica Gorzelitz NCI / DCEG / MEB PLCO Sep 10, 2020 PLCO-665
DNA methylation and breast cancer risk Jirong Long Vanderbilt University Medical Center PLCO Sep 1, 2020 PLCO-663
Consumption of sugar, sugar-sweetened beverages and liver cancer Katherine McGlynn National Cancer Institute PLCO Sep 1, 2020 PLCO-664
Estimate heritability of survival for selected diseases Jianxin Shi National Cancer Institute PLCO Aug 20, 2020 PLCO-661